Skip to main content
Clinical Trials/NCT05513248
NCT05513248
Completed
Not Applicable

Perioperative Outcomes of Anatomic Lung Resections in Patients Who Recovered From Coronavirus Disease 2019 (COVID-19): a Two-Year Retrospective Case Series

Lung Center of the Philippines1 site in 1 country16 target enrollmentOctober 10, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19
Sponsor
Lung Center of the Philippines
Enrollment
16
Locations
1
Primary Endpoint
Major complication rate
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This study will determine the outcomes of anatomic lung resections in patients who recovered from coronavirus disease 2019 (COVID-19) disease by describing the morbidity and mortality as well as the length of postoperative hospital stay.

Detailed Description

This study will be conducted at the Lung Center of the Philippines. The study design is a retrospective case series implemented via chart review. Online and written patient records will be reviewed to determine the baseline patient characteristics and the preoperative outcomes. Patients who recovered from COVID-19 will be selected from those who underwent anatomic lung resection from June 1, 2020 to May 31, 2022. This study will be done in accordance with the Helsinky Declaration and Good Clinical Practice Guidelines, and will be subject for approval of the institutional Ethics and Technical Review Boards. Descriptive statistics will be used to describe patient characteristics and perioperative outcomes.

Registry
clinicaltrials.gov
Start Date
October 10, 2022
End Date
November 1, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Lung Center of the Philippines
Responsible Party
Principal Investigator
Principal Investigator

Alexander H. Tuliao

Medical Officer III

Lung Center of the Philippines

Eligibility Criteria

Inclusion Criteria

  • underwent anatomic lung resection
  • previous COVID-19 infection documented by nasopharyngeal swab RT-PCR or GeneXpert
  • with negative nasopharyngeal swab RT-PCR or GeneXpert prior to lung resection

Exclusion Criteria

  • with incomplete patient records

Outcomes

Primary Outcomes

Major complication rate

Time Frame: perioperative period (up to 30 days after anatomic lung resection)

proportion of patients who develop acute kidney injury, acute myocardial infarction, acute respiratory distress syndrome (ARDS), acute respiratory failure, atelectasis requiring intervention, bronchopleural fistula, empyema thoracis, hemothorax, pneumonia, stroke or venous thromboembolism

Minor complication rate

Time Frame: perioperative period (within 30 days after anatomic lung resection)

proportion of patients who develop atrial fibrillation, pneumothorax or prolonged air leak

Length of postoperative hospital stay

Time Frame: perioperative period (up to 30 days after anatomic lung resection)

time duration from surgery to discharge order

Mortality rate

Time Frame: perioperative period (up to 30 days after anatomic lung resection)

proportion of patients who died due to perioperative complications

Study Sites (1)

Loading locations...

Similar Trials